Related Experiment Video
Updated: Dec 29, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Usefulness of the ACTEL Score to Predict Atrial Fibrillation in Patients with Cryptogenic Stroke
Antonio Muscari1,2, Pietro Barone3, Luca Faccioli4
1Stroke Unit, Medical Department of Continuity of Care and Disability, S.Orsola-Malpighi Hospital, Bologna, Italy, antonio.muscari@unibo.it.
Insights
The ACTEL score helps identify patients with atrial fibrillation (AF) after ischemic stroke. This new score, derived from patient data, offers high accuracy in detecting AF in cryptogenic stroke cases.
Area of Science:
- Neurology
- Cardiology
- Medical Diagnostics
Background:
- Assessing undetected atrial fibrillation (AF) in ischemic stroke patients is crucial.
- Previous research developed the MrWALLETS score for AF detection.
- Cryptogenic stroke (CS) patients are a key group for AF screening.
Purpose of the Study:
- To develop and validate a new scoring system, ACTEL, for identifying AF in ischemic stroke patients.
- To improve upon the existing MrWALLETS score.
- To utilize cryptogenic stroke patients as a control group for AF detection.
Main Methods:
- Retrospective analysis of 191 ischemic stroke patients (68 with AF, 123 with CS).
- Data collected included brain CT scans, echocardiography, ultrasound, ECG monitoring, and cardiovascular risk factor assessment.
- Logistic regression analysis was used to identify independent predictors of AF.
Main Results:
- The ACTEL score comprises 5 variables: Age ≥75, hypercholesterolemia, tricuspid regurgitation, left ventricular end-diastolic volume, and left atrium size.
- The score demonstrated an area under the receiver operating characteristic curve of 0.80 for AF identification.
- A cutoff of ≥2 yielded a positive predictive value of 80.8% and specificity of 92.7%.
Conclusions:
- The ACTEL score is a simplified and improved tool for identifying patients with first-diagnosed AF.
- It is particularly effective in the context of cryptogenic strokes.
- The score offers a high positive predictive value for AF detection.
Introduction:
To assess the probability of undetected atrial fibrillation (AF) in patients with ischemic stroke, we previously compared patients who were first diagnosed with AF with patients with large or small artery disease and obtained the MrWALLETS 8-item scoring system. In the present study, we utilized cryptogenic strokes (CS) as the control group, as AF is normally sought among CS patients.
Methods:
We retrospectively examined 191 ischemic stroke patients (72.5 ± 12.6 years), 68 with first diagnosed AF and 123 with CS, who had undergone 2 brain CT scans, echocardiography, carotid/vertebral ultrasound, continuous electrocardiogram monitoring and anamnestic/laboratory search for cardiovascular risk factors.
Results:
In logistic regression, 5 variables were independently associated with AF, forming the "ACTEL" score: Age ≥75 years (OR 2.42, 95% CI 1.18-4.96, p = 0.02; +1 point); hyperCholesterolemia (OR 0.38, 95% CI 0.18-0.78, p = 0.009; -1 point); Tricuspid regurgitation ≥ mild-to-moderate (OR 4.99, 95% CI 1.63-15.27, p = 0.005; +1 point); left ventricular End-diastolic volume <65 mL (OR 7.43, 95% CI 2.44-22.6, p = 0.0004; +1 point); Left atrium ≥4 cm (OR 4.57, 95% CI 1.97-10.62, p = 0.0004; +1 point). The algebraic sum of these points may range from -1 to +4. For AF identification, the area under the receiver operating characteristic curve was 0.80 (95% CI 0.73-0.87). With a cutoff of ≥2, positive predictive value was 80.8%, specificity 92.7% and sensitivity 55.9%.
Conclusions:
The ACTEL score, a simplified and improved version of the MrWALLETS score, allows the identification of patients with first diagnosed AF, in the context of CSs, with a high positive predictive value.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Dysrhythmias V: Evaluating Dysrhythmias
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis III: Management

